From the category archives:
To Bristol Myers Squibb, the makers of Plavix: Perhaps your scare tactics will eventually backfire. Lots of folks out there have a very negative reaction to your gurney ads.. You’re making a major marketing mistake — Why not market an anti-anxiety pharmaceutical at the same time you are scaring people to death? (On the other [...]
{ 0 comments }
Continuing the theme of tasteless Plavix ads…. From www.thiscommericalsucks.com Wednesday, December 2, 2009 Ask your Daughter–errrr, Doctor- about Plavix Daughter with waaaaayy too much time on her hands- and too much control over her dad- is staring at a laptop screen conveniently (?) located on the kitchen table when she commands her father’s attention- “Dad? [...]
{ 0 comments }
Note that this study was funded by Bristol-Myers-Squibb, the makers of Plavix. Double-Dose Plavix Benefits Certain Patients, Study Finds And higher-dose aspirin is no more effective than low dose, researchers say Wednesday, September 1, 2010 (HealthDay News) – - More isn’t necessarily better when prescribing the two drugs commonly used to treat patients who are [...]
{ 0 comments }
This was the original research in the prestigious New England Journal of Medicine comparing Prasugrel (Brilinta) with Clopidogrel (Plavix.) The bottom line is that while Brilinta prevented more deaths from heart attacks, it increased the risk of fatal bleeding… No difference it fatal outcomes, take your pick. (Why am I thinking of Robert Frost’s Poem [...]
{ 0 comments }
This is an article written by Merrill Goozner, an independent journalist. Sure makes the whole industry looks suspicious (no surprise, of course). Yes, why not aspirin? About Mr. Goozer: In April 2004, the University of California Press published his first book, “The $800 Million Pill: The Truth Behind the Cost of New Drugs,” an exposé [...]
{ 0 comments }
I have been following heart information on the web for many years. In my opinion, Dr. Fogoros column provides the best heart information out there: The Plavix “Rebound Phenomenon” Higher risk of cardiac events immediately after stopping Plavix By Richard N. Fogoros, M.D., March 14, 2008 An article in the Journal of the American Medical [...]
{ 0 comments }
This issue of differential metabolizing also came up in the earlier posts about coffee. Again, the problem is that we all are different in how we metabolize drugs: how do you tailor the drug to the person? Booster Shots Oddities, musings and news from the health world The FDA requires a black-box warning on anti-clotting [...]
{ 0 comments }
